Indolent Systemic Mastocytosis

Known as: Indolent Systemic Mastocytoses, Systemic Mastocytoses, Indolent, Mastocytoses, Indolent Systemic 
An indolent mast cell neoplasm characterized by systemic infiltration of skin and internal organs by aggregates of neoplastic mast cells. There is no… (More)
National Institutes of Health

Related topics

Related topics

19 relations
Aggressive Systemic MastocytosisBone MarrowBone marrow stem cellC-KIT Gene
(More)

Broader (1)

Mastocytosis, Systemic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
OBJECTIVE We systematically assessed bone mineral density (BMD), bone turnover markers (BTM), and fractures in a large cohort of… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.
BACKGROUND Indolent systemic mastocytosis is a group of rare diseases for which reliable predictors of progression and outcome… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors.
Clinical phenotype in systemic mastocytosis (SM) is markedly variable, which complicates prognostication and decision making… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
BACKGROUND Anaphylaxis after Hymenoptera stings has been reported in subjects with mastocytosis, but few data exist regarding… (More)
  • figure 1
  • figure 2
  • table I
  • table II
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Design of a Dual-Band Implantable Antenna and Development of Skin Mimicking Gels for Continuous Glucose Monitoring
In this study, we present a small-size dual medical implant communications service (MICS) (402-405 MHz) and industrial… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
Review
2007
Review
2007
Mastocytosis: state of the art.
Mastocytosis is a neoplastic disease involving mast cells (MC) and their CD34+ progenitors. Symptoms in mastocytosis are caused… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2005
Review
2005
Mastocytosis: pathology, genetics, and current options for therapy.
Mast cell disorders are defined by an abnormal accumulation of tissue mast cells (MCs) in one or more organ systems. Symptoms in… (More)
  • table I
  • figure 1
  • table II
  • table IV
  • table III
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Design criteria for the RF section of UHF and microwave passive RFID transponders
A set of design criteria for the radio-frequency (RF) section of long-range passive RF identification (RFID) transponders… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity
BACKGROUND Controlled clinical trials of health care interventions are either explanatory or pragmatic. Explanatory trials test… (More)
Is this relevant?
Review
2001
Review
2001
Diagnostic criteria and classification of mastocytosis: a consensus proposal.
The term 'mastocytosis' denotes a heterogeneous group of disorders characterized by abnormal growth and accumulation of mast… (More)
Is this relevant?